Uploaded April 2026 | Updated September 2026, 1 week ago
Animal models of gene therapy targeting the IQSEC2 mutation have demonstrated benefits in social behavior abnormalities, abnormal seizure susceptibility, and impaired growth across independent laboratories and models. Learn more about gene therapy research and potential for clinical trials in Dr. Levy's recent webinar here: autism.org/gene-therapy-for-mutations-in-the-iqsec2-gene
Animal models of gene therapy targeting the IQSEC2 mutation have demonstrated benefits in social behavior abnormalities, abnormal seizure susceptibility, and impaired growth across independent laboratories and models. Learn more about gene therapy research and potential for clinical trials in Dr. Levy's recent webinar here: autism.org/gene-therapy-for-mutations-in-the-iqsec2-gene
